Netherlands Heart Journal最新文献

{"title":"CT is the new standard for the diagnosis of coronary artery disease in daily practice.","authors":"José P S Henriques, R Nils Planken","doi":"10.1007/s12471-024-01907-2","DOIUrl":"10.1007/s12471-024-01907-2","url":null,"abstract":"","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"369-370"},"PeriodicalIF":1.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11502707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of artificial intelligence in coronary CT angiography.","authors":"Rudolf L M van Herten, Ioannis Lagogiannis, Tim Leiner, Ivana Išgum","doi":"10.1007/s12471-024-01901-8","DOIUrl":"10.1007/s12471-024-01901-8","url":null,"abstract":"<p><p>Coronary CT angiography (CCTA) offers an efficient and reliable tool for the non-invasive assessment of suspected coronary artery disease through the analysis of coronary artery plaque and stenosis. However, the detailed manual analysis of CCTA is a burdensome task requiring highly skilled experts. Recent advances in artificial intelligence (AI) have made significant progress toward a more comprehensive automated analysis of CCTA images, offering potential improvements in terms of speed, performance and scalability. This work offers an overview of the recent developments of AI in CCTA. We cover methodological advances for coronary artery tree and whole heart analysis, and provide an overview of AI techniques that have shown to be valuable for the analysis of cardiac anatomy and pathology in CCTA. Finally, we provide a general discussion regarding current challenges and limitations, and discuss prospects for future research.</p>","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"417-425"},"PeriodicalIF":1.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11502768/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142470360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Demographics and outcomes of patients younger than 75 years undergoing aortic valve interventions in Rotterdam.","authors":"Rik Adrichem, A Maarten Mattace-Raso, Thijmen W Hokken, Mark M P van den Dorpel, Marjo J A G de Ronde, Mattie J Lenzen, Paul A Cummins, Isabella Kardys, Rutger-Jan Nuis, Joost Daemen, Jos A Bekkers, Nicolas M Van Mieghem","doi":"10.1007/s12471-024-01888-2","DOIUrl":"10.1007/s12471-024-01888-2","url":null,"abstract":"<p><strong>Background: </strong>Transcatheter aortic valve implantation (TAVI) is considered a safe and effective alternative to surgical aortic valve replacement (SAVR) for elderly patients across the operative risk spectrum. In the Netherlands, TAVI is reimbursed only for patients with a high operative risk. Despite this, one fifth of TAVI patients are < 75 years of age. We aim to compare patient characteristics and outcomes of TAVI and SAVR patients < 75 years.</p><p><strong>Methods: </strong>This study included all patients < 75 years without active endocarditis undergoing TAVI or SAVR for severe aortic stenosis, mixed aortic valve disease or degenerated aortic bioprosthesis between 2015 and 2020 at the Erasmus University Medical Centre. Dutch authority guidelines were used to classify operative risk.</p><p><strong>Results: </strong>TAVI was performed in 292 patients, SAVR in 386 patients. Based on the Dutch risk algorithm, 59.6% of TAVI patients and 19.4% of SAVR patients were at high operative risk. There was no difference in 30-day all-cause mortality between TAVI and SAVR (2.4% vs 0.8%, p = 0.083). One-year and 5‑year mortality was higher after TAVI than after SAVR (1-year: 12.5% vs 4.3%, p < 0.001; 5‑year: 36.8% vs 12.0%, p < 0.001). Within risk categories we found no difference between treatment strategies. Independent predictors of mortality were cardiovascular comorbidities (left ventricular ejection fraction < 30%, atrial fibrillation, pulmonary hypertension) and the presence of malignancies, liver cirrhosis or immunomodulatory drug use.</p><p><strong>Conclusion: </strong>At the Erasmus University Medical Centre, in patients < 75 years, TAVI is selected for higher-risk phenotypes and overall has higher long-term mortality than SAVR. We found no evidence for worse outcome within risk categories.</p>","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"348-355"},"PeriodicalIF":1.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implantable cardioverter-defibrillators might not be necessary in all patients with idiopathic ventricular fibrillation.","authors":"Alwin B P Noordman, Alexander H Maass","doi":"10.1007/s12471-024-01898-0","DOIUrl":"10.1007/s12471-024-01898-0","url":null,"abstract":"","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"365"},"PeriodicalIF":1.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trends in adoption of extravascular cardiac implantable electronic devices: the Dutch cohort.","authors":"Karel T N Breeman, Reinoud E Knops, Michelle D van der Stoel, Lucas V A Boersma, Sing-Chien Yap, Lieselot van Erven, Vincent F van Dijk, Alexander H Maass, Arthur A M Wilde, Fleur V Y Tjong","doi":"10.1007/s12471-024-01892-6","DOIUrl":"10.1007/s12471-024-01892-6","url":null,"abstract":"<p><strong>Introduction: </strong>Conventional implantable cardioverter-defibrillators (ICDs) and pacemakers carry a risk of pocket- and lead-related complications in particular. To avoid these complications, extravascular devices (EVDs) have been developed, such as the subcutaneous ICD (S-ICD) and leadless pacemaker (LP). However, data on patient or centre characteristics related to the actual adoption of EVDs are lacking.</p><p><strong>Objective: </strong>To assess real-world nationwide trends in EVD adoption in the Netherlands.</p><p><strong>Methods: </strong>Using the Netherlands Heart Registration, all consecutive patients with a de novo S‑ICD or conventional single-chamber ICD implantation between 2012-2020, or de novo LP or conventional single-chamber pacemaker implantation between 2014-2020 were included. Trends in adoption are described for various patient and centre characteristics.</p><p><strong>Result: </strong>From 2012-2020, 2190 S‑ICDs and 10,683 conventional ICDs were implanted; from 2014-2020, 712 LPs and 11,103 conventional pacemakers were implanted. The general use has increased (S-ICDs 8 to 21%; LPs 1 to 8%), but this increase seems to have reached a plateau. S‑ICD recipients were younger than conventional ICD recipients (p < 0.001) and more often female (p < 0.001); LP recipients were younger than conventional pacemaker recipients (p < 0.001) and more often male (p = 0.03). Both S‑ICDs and LPs were mainly implanted in high-volume centres with cardiothoracic surgery on-site, although over time S‑ICDs were increasingly implanted in centres without cardiothoracic surgery (p < 0.001).</p><p><strong>Conclusion: </strong>This nationwide study demonstrated a relatively quick adoption of innovative EVDs with a plateau after approximately 4 years. S‑ICD use is especially high in younger patients. EVDs are mainly implanted in high-volume centres with cardiothoracic surgery back-up, but S‑ICD use is expanding beyond those centres.</p>","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"356-362"},"PeriodicalIF":1.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Strengthening NVVC endorsements for ESC guidelines.","authors":"Pim van der Harst","doi":"10.1007/s12471-024-01905-4","DOIUrl":"10.1007/s12471-024-01905-4","url":null,"abstract":"","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":"32 10","pages":"337"},"PeriodicalIF":1.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413258/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142291596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcatheter aortic valve implantation under 75 years of age: only for high surgical risk patients; but for how long?","authors":"Michiel Voskuil, Michael G Dickinson","doi":"10.1007/s12471-024-01900-9","DOIUrl":"10.1007/s12471-024-01900-9","url":null,"abstract":"","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"346-347"},"PeriodicalIF":1.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413247/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142109661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reply to 'Implantable cardioverter-defibrillators might not be necessary in all patients with idiopathic ventricular fibrillation'.","authors":"Lisa M Verheul, Rutger J Hassink","doi":"10.1007/s12471-024-01899-z","DOIUrl":"10.1007/s12471-024-01899-z","url":null,"abstract":"","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"366"},"PeriodicalIF":1.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact and limitations of 3D computational modelling in transcatheter mitral valve replacement—a two-centre Dutch experience","authors":"Mark M. P. van den Dorpel, Mauricio Felippi de Sá Marchi, Zouhair Rahhab, Joris F. Ooms, Rik Adrichem, Sarah Verhemel, Claire Ben Ren, Rutger-Jan Nuis, Joost Daemen, Alexander Hirsch, Ben J. L. Van den Branden, Nicolas M. Van Mieghem","doi":"10.1007/s12471-024-01893-5","DOIUrl":"https://doi.org/10.1007/s12471-024-01893-5","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Transcatheter mitral valve replacement (TMVR) has emerged as a minimally invasive alternative to mitral valve surgery for patients at high or prohibitive operative risk. Prospective studies reported favourable outcomes in patients with annulus calcification (valve-in-mitral annulus calcification; ViMAC), failed annuloplasty ring (mitral valve-in-ring; MViR), and bioprosthetic mitral valve dysfunction (mitral valve-in-valve; MViV). Multi-slice computed tomography (MSCT)-derived 3D-modelling and simulations may provide complementary anatomical perspectives for TMVR planning.</p><h3 data-test=\"abstract-sub-heading\">Aims</h3><p>We aimed to illustrate the implementation of MSCT-derived modelling and simulations in the workup of TMVR for ViMAC, MViR, and MViV.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>For this retrospective study, we included all consecutive patients screened for TMVR and compared MSCT data, echocardiographic outcomes and clinical outcomes.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Sixteen out of 41 patients were treated with TMVR (ViMAC <i>n</i> = 9, MViR <i>n</i> = 3, MViV <i>n</i> = 4). Eleven patients were excluded for inappropriate sizing, 4 for anchoring issues and 10 for an unacceptable risk of left ventricular outflow tract obstruction (LVOTO) based on 3D modelling. There were 3 procedure-related deaths and 1 non-procedure-related cardiovascular death during 30 days of follow-up. LVOTO occurred in 3 ViMAC patients and 1 MViR patient, due to deeper valve implantation than planned in 3 patients, and anterior mitral leaflet displacement with recurrent basal septum thickening in 1 patient. TMVR significantly reduced mitral mean gradients as compared with baseline measurements (median mean gradient 9.5 (9.0–11.5) mm Hg before TMVR versus 5.0 (4.5–6.0) mm Hg after TMVR, <i>p</i> = 0.03). There was no residual mitral regurgitation at 30 days.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>MSCT-derived 3D modelling and simulation provide valuable anatomical insights for TMVR with transcatheter balloon expandable valves in ViMAC, MViR and MViV. Further planning iterations should target the persistent risk for neo-LVOTO.</p>","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":"14 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2023 European Society of Cardiology guidelines for the management of acute coronary syndromes","authors":"Bastiaan Zwart, Bimmer E. P. M. Claessen, Peter Damman, Pier Woudstra, Maarten A. Vink, J. Willem Balder, Michael G. Dickinson, Erik A. Badings, Yolande Appelman, Arnoud W. J. van ’t Hof, Jurriën M. ten Berg, Fatih Arslan","doi":"10.1007/s12471-024-01896-2","DOIUrl":"https://doi.org/10.1007/s12471-024-01896-2","url":null,"abstract":"<p>This review discusses the new recommendations in the 2023 European Society of Cardiology guidelines on the management of acute coronary syndrome and provides a perspective on topics specific to clinical practice in the Netherlands, including pre-treatment, antiplatelet agent strategies, the use of risk scores and logistical considerations with regard to the timing of coronary angiography.</p>","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":"43 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142191124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}